Status:
COMPLETED
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
Lead Sponsor:
University of Pennsylvania
Conditions:
Breast Cancer
Eligibility:
FEMALE
39-48 years
Phase:
NA
Brief Summary
In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Penn...
Detailed Description
In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Penn...
Eligibility Criteria
Inclusion
- Women ages 39-48
- Patient of one of the nine primary care or OB/GYN practices that are participating in the study
- Must have had an appointment at one of these locations in the past 24 months
- Must have an appointment during the study period
- Woman has not yet initiated breast cancer screening (no prior mammogram)
- No history of breast cancer
Exclusion
- Prior diagnosis of breast cancer
- Major comorbidity that substantially affects their 10 year mortality
- Non-English speaker
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2017
Estimated Enrollment :
1302 Patients enrolled
Trial Details
Trial ID
NCT01879189
Start Date
September 1 2013
End Date
November 1 2017
Last Update
November 29 2018
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Edward S. Cooper Internal Medicine
Philadelphia, Pennsylvania, United States, 19104
2
Family Medicine St. Leonard's Court
Philadelphia, Pennsylvania, United States, 19104
3
Family Medicine
Philadelphia, Pennsylvania, United States, 19104
4
Helen O. Dickens Center for Women's Health
Philadelphia, Pennsylvania, United States, 19104